
Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- COVID-19-related research market cap changes in biopharma companies Feb 2020
- Covid-19 tests emergency authorized by FDA 20th March 2020, by price move
- Covid-19 tests emergency authorized by FDA 17th March 2020, by turnaround time
- Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Number of coronavirus (COVID-19) deaths in the U.S. as of March 2, 2021, by race
- COVID-19 mortality rate in the U.S. from Dec.8, 2020 to Mar. 2, 2021, by race
- Asian COVID-19 deaths vs population in select U.S. states as of June 23, 2020
- COVID-19 death rates among white U.S. residents as of March 2, 2021, by state
- Coronavirus (COVID-19) death rate in the U.S. as of March 2, 2021, by race
- COVID-19 Latino death rates in the U.S. as of March 2, 2021, by state
- COVID-19 fatality rate as of February 28, 2020, by gender
- Black COVID-19 deaths vs population in select U.S. states as of June 23, 2020
- Indigenous COVID-19 deaths vs population in select U.S. states as of June 23, 2020
- COVID-19 Black death rates in the U.S. as of March 2, 2021, by state
- Latino COVID-19 deaths vs population in select U.S. states as of June 23, 2020
- COVID-19 Asian death rates in the U.S. as of March 2, 2021, by state
- Depression and anxiety in quarantined and non-quarantined individuals in Poland 2020
Vantage. (February 27, 2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 [Graph]. In Statista. Retrieved August 16, 2022, from https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020." Chart. February 27, 2020. Statista. Accessed August 16, 2022. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. (2020). Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020. Statista. Statista Inc.. Accessed: August 16, 2022. https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage. "Share Price Changes of Select Biopharmaceutical Companies Involved in Coronavirus (Covid-19) Research from January 20 to February 25, 2020." Statista, Statista Inc., 27 Feb 2020, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/
Vantage, Share price changes of select biopharmaceutical companies involved in coronavirus (COVID-19) research from January 20 to February 25, 2020 Statista, https://www.statista.com/statistics/1103603/coronavirus-related-share-price-changes-in-biopharma/ (last visited August 16, 2022)